Clinical Trial to Evaluate the Efficacy and Safety of DWKH

Phase III Clinical Trial to Evaluate the Efficacy and Safety of DWKH

Randomized, Double-blind, Parellel, Multicenter, Active-controlled

Inclusion Criteria:

• Male and female aged between 19 and 80.
• Patients whose BSS score is over 5.

Exclusion Criteria:

• Patients allergic to any ingredients of the study drugs.
• Moderate liver disease (ALT or AST > UNLx3).
• Moderate lung disease.
• Uncontrolled HTN.
• Uncontrolled DM.
• Uncontrolled thyroidism.
• Patients who is needed antibiotics during the study period.
• In the case of women, pregnant(Urine-HCG positive) or lactating women.